Wednesday, November 16, 2016
Print Current Session:
|
|
Wednesday
SESSION 34:
IMPORTANT ISSUES FOR VASCULAR SURGEONS AND SPECIALISTS; REMEMBRANCES; ASSET PROTECTION; KEY MEDICAL, HISTORICAL AND ETHICAL TOPICS
Moderators:Bruce A. Perler, MD, MBA / James C. Stanley, MD
|
|
SESSION 34 SCHEDULE | |
10:16 AM - 10:21 AM | Giants No Longer With Us: A Tribute To Allan Callow, Calvin Ernst And John (Jack) Connolly |
Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd | |
View Slides in PDF | |
10:22 AM - 10:27 AM | Predictions For The Future In The Treatment Of Vascular Disease: Where Is Vascular Surgery Going |
Presenter(s):Mark A. Adelman, MD | |
View Slides in PDF | |
10:28 AM - 10:33 AM | Negotiating With Large Health Care Systems: Tips And Tricks For Individual Vascular Surgeons: How Could A Union Or Society Help |
Presenter(s):Timothy M. Sullivan, MD | |
View Slides in PDF | |
10:34 AM - 10:39 AM | Beyond Vascular Surgery For Vascular Surgeons: Working With Industry: What Is Good About It And What Is Bad |
Presenter(s):David H. Deaton, MD, FACS | |
View Slides in PDF | |
10:40 AM - 10:45 AM | Why Vascular Surgeons Are An Essential Operating Room Resource For Other Surgeons: They Must Be Valued As Such, Protected And Compensated |
Presenter(s):Gregory L. Moneta, MD | |
View Slides in PDF | |
10:46 AM - 10:51 AM | Is It A Wild West Bonanza Or A Feeding Frenzy: How To Stem The Surge In Unnecessary Lower Extremity Interventions That Cost So Much And Do Little To Benefit Patients |
Presenter(s):Scott L. Stevens, MD | |
View Slides in PDF | |
10:52 AM - 10:57 AM | Key Points In Asset Protection, Tax Planning And Succession Planning For Vascular Surgeons/Specialists |
Presenter(s):Hillel Presser, Esq., MBA | |
View Slides in PDF | |
10:58 AM - 11:04 AM | Panel Discussion |
KEY NON-SURGICAL ISSUES | |
Moderator(s): Michael L. Marin, MD / Frank J. Veith, MD | |
11:04 AM - 11:09 AM | Optimal Treatment For Left Main Coronary Lesion Is Changing: Stenting With DESs Is Replacing Open Coronary Bypass: Based On The EXCEL Trial |
Presenter(s):Gregg W. Stone, MD | |
View Slides in PDF | |
11:10 AM - 11:15 AM | COURAGE Trial Findings After 15 Years Follow-Up: It Still Shows No Advantage Over Medical Treatment In Some Coronary Disease Patients: Are Too Many Patients Getting Coronary Stents |
Presenter(s):Roxana Mehran, MD | |
View Slides in PDF | |
11:16 AM - 11:21 AM | Role Of Stents In The Treatment Of Lower Extremity Occlusive Lesions: Value Of DESs And DCBs: Will Bare Metal Stent Usage Decrease Or Disappear |
Presenter(s):John H. Rundback, MD, FSIR, FAHA | |
View Slides in PDF | |
11:22 AM - 11:27 AM | Current Status Of Cell And Gene Therapy For CLI Treatment: Do Either Have A Future |
Presenter(s):Sigrid Nikol, MD | |
View Slides in PDF | |
11:28 AM - 11:33 AM | Long-Term Results Of Autologous Bone Marrow Cell Treatment For No Option CLI: Results Of A Double Blinded RCT |
Presenter(s):Thomas F. O'Donnell, Jr., MD / Mark D. Iafrati, MD | |
View Slides in PDF | |
AN HISTORICAL NOTE | |
11:34 AM - 11:39 AM | What Are “Octopus” Endografts: Why Are They The Future Of Branched Endografting For TAAAs And What Is Their Origin |
Presenter(s):Karthikeshwar Kasirajan, MD | |
View Slides in PDF | |
ETHICAL ISSUES | |
11:40 AM - 11:45 AM | Ethical Conflicts In Providing Quality Care With All The Financial And RVU Pressures In The Current Health Care System: How To Resolve Them |
Presenter(s):James W. Jones, MD, PhD, MHA | |
View Slides in PDF | |
11:46 AM - 11:51 AM | How To Involve Vascular Patients In Decision Making About Their Surgical And Interventional Treatments |
Presenter(s):Dirk T. Ubbink, MD, PhD | |
View Slides in PDF | |
11:52 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 34 | |
previous | next |